It was a project with special significance for OPASCA – in an impressive team effort, 10.000 units of medication for the treatment of COVID-19 were safely delivered to Tashkent, Uzbekistan. There has been an ongoing transfer of know how in the field of oncology for years. Alongside these efforts, we are pleased with the possibility to contribute to the fight against COVID-19. A special thank you to everyone who helped making this possible: German Ministry of Health, German Armed Forces, German Embassy, Uzbek Embassy, Uzbekistan airways, eutecma GmbH, Logistics4Pharma (L4P), Robert Koch Institute and Charité

 

About OPASCA

As a medical technology company with more than ten years of experience in digitization and ensuring highly efficient and secure processes in clinics, hospitals and doctors’ practices, OPASCA offers digital solutions to meet the challenges of future-proof, patient-centric healthcare. The company, headquartered in the Mannheim Technology Park, has successfully digitized clinical facilities in more than 140 projects and in over 20 countries. OPASCA is also involved in underdeveloped countries and, for example, is supporting the establishment of a nationwide sustainable care structure for cancer patients in Uzbekistan, Central Asia, in close cooperation with the German government, the German Society for International Cooperation (GIZ) and an interdisciplinary partner network. In Germany, six out of ten top clinics in the Focus Clinic List 2021 already rely on the expertise of the digital health specialist.